Comparing two Russian-developed neuropeptides with distinct parent sequences. Understanding ACTH-derived vs Tuftsin-derived mechanisms for neuroscience research.
| Category | Semax | Selank |
|---|---|---|
| Compound Type | ACTH(4-7) analogue peptide | Tuftsin analogue peptide |
| Amino Acid Length | 7 amino acids | 7 amino acids |
| Origin/Design | ACTH fragment derivative | Tuftsin derivative |
| Primary Research Focus | Cognitive/nootropic studies | Anxiolytic/immunomodulatory studies |
| Key Pathway | BDNF, neurotrophic signaling | GABA, enkephalinase inhibition |
| Development Origin | Russian Institute research | Russian Institute research |
| Purity Standard | ≥98% HPLC verified | ≥98% HPLC verified |
| Stability | Good (PGP modification) | Good (PGP modification) |
Semax is a synthetic heptapeptide with the sequence Met-Glu-His-Phe-Pro-Gly-Pro. It was developed at the Institute of Molecular Genetics in Russia as a derivative of ACTH(4-7), the biologically active fragment of adrenocorticotropic hormone. The C-terminal Pro-Gly-Pro addition (PGP tripeptide) enhances stability and bioavailability.
Semax research applications focus on:
Semax is particularly interesting for researchers studying neurotrophic factors and their role in neural plasticity, as it has been reported to influence BDNF and other growth factor expression in laboratory models.
Selank is a synthetic heptapeptide with the sequence Thr-Lys-Pro-Arg-Pro-Gly-Pro. It was developed at the same Russian institute as Semax but derives from tuftsin (Thr-Lys-Pro-Arg), a natural tetrapeptide immunomodulator. Like Semax, it incorporates the stabilizing Pro-Gly-Pro C-terminal modification.
Selank research applications include:
Selank's dual heritage from tuftsin (immunomodulatory) combined with central nervous system activity makes it an interesting research tool for studying neuroimmune interactions and stress-related signaling pathways.
While both peptides are studied in neuroscience contexts, their different parent sequences lead to distinct research applications. Selection depends on the specific pathways under investigation.
Both peptides share the PGP stabilization modification:
Standard peptide storage protocols apply:
Both Semax and Selank were developed at the Institute of Molecular Genetics of the Russian Academy of Sciences in Moscow. They represent a class of regulatory peptides designed with the Pro-Gly-Pro stabilization strategy. This common development background provides some advantages for comparative research:
Both peptides include ≥98% purity verification. Browse our complete peptide catalog or explore research compounds available in Canada with COA documentation.
In research settings, the reliability of results depends entirely on the quality and consistency of materials used. Third-party verification provides an objective baseline for researchers to trust their experimental inputs.
Independent laboratory verification ensures unbiased purity and identity confirmation.
Each production batch is individually tested and documented for reproducibility.
HPLC and mass spectrometry verification for research-grade quality assurance.
Complete Certificates of Analysis available for every product and batch.
We're committed to providing researchers with consistently high-quality compounds, transparent documentation, and reliable service across Canada.
Fast domestic shipping from within Canada, reducing transit times and customs delays.
Every batch verified by third-party laboratories for purity and identity confirmation.
Clear labeling and documentation designed for legitimate research applications.
Rigorous QC protocols ensure batch-to-batch consistency for reliable research outcomes.
Semax is derived from ACTH(4-7), the 4-7 fragment of adrenocorticotropic hormone, with a C-terminal Pro-Gly-Pro addition. Selank is derived from tuftsin (a natural immunomodulatory tetrapeptide) with the same Pro-Gly-Pro modification for stability.
Semax research typically focuses on cognitive function, neurotrophic factor expression (particularly BDNF), and neuroprotective mechanisms. Selank research emphasizes anxiolytic mechanisms, GABAergic modulation, and immunomodulatory pathways.
Both peptides incorporate a C-terminal Pro-Gly-Pro (PGP) sequence developed at the Institute of Molecular Genetics. This modification enhances proteolytic stability and extends the peptides' activity in research models.
Both should include COAs with HPLC purity (≥98%), mass spectrometry identity confirmation, and peptide content analysis. Sequence verification is important given their specific modified structures.
Both peptides are available as research compounds from qualified suppliers. They are labeled for research use only with appropriate documentation for laboratory applications in Canada.
All products include third-party testing documentation, batch-specific Certificates of Analysis, and secure checkout. For research use only.
Research Use Only: Products are intended for laboratory and scientific research purposes only. Not for human or veterinary use. By purchasing, you confirm compliance with all applicable regulations.